Intra-Cellular Therapies Inc. News
Intra-Cellular Therapies, Watford Holdings: Top Stock Gainers for Wednesday
Intra-Cellular Therapies, Watford Holdings, Trillium Therapies, Vivent Smart Home and DiamondPeak are among top stock gainers for Wednesday.
Intra-Cellular Leaps on Signs of Fewer Side Effects With Schizophrenia Drug
Standard treatments can cause motor side effects and/or weight gain, cardiovascular complications, dyslipidemia, and hyperglycemia.
Intra-Cellular Evades Scrutiny on Schizophrenia Drug Safety, Shares Plunge
Today's Intra-Cellular update was probably going to send the stock price falling regardless of how management acted, but the refusal to be transparent made a bad day even worse.
Biotech Movers: Intra-Cellular Therapies, Organovo, Acorda
Intra-Cellular Therapies, Organovo Holdings and Acorda Therapeutics were among the biotech stock movers in premarket trading on Monday.
The 'Gnarly 9' biotechs will test FDA mettle
The firms all have drugs they want the feds to bend the rules to approve.
Morningstar's Five Coping Mechanisms for Bear Market
The S&P 500 is in a bear market, having lost 20% so far this year. So what’s an investor to do?
Economist Roubini: Why Stocks Poised for 50% Wipeout
The stock market is off to its worst start to a year since 1962, with the S&P 500 dropping 21% in the first half of 2022.
Who Is the Mystery Crypto Queen on the Run After an Alleged Scam?
The FBI is offering anyone who helps arrest OneCoin co-founder Dr. Ruja Ignatova $100,000.